ATRA
Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1/2
- Enrollment
- 42 patients (estimated)
- Sponsors
- Houston Methodist Hospital Research Institute, Houston Methodist Hospital Research Institute
- Collaborators
- Cancer Prevention Research Institute of Texas
- Tags
- Vitamins
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1975
- NCT Identifier
- NCT06536413
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.